Japan's Pharmaceuticals and Medical Devices Agency (PMDA) is set to fully implement eCTD v4.0 by April 2026, aligning with global regulatory bodies like the US FDA and EMA. This transition aims to standardize submission structures, content, and terminology, enhancing efficiency for multi-regional submissions. The blog outlines Japan's adoption timeline, compares it with other regions,... https://throbsocial.com/story22305061/japan-and-the-global-ectd-v4-0-wave-timelines-trends-readiness